THE FORMULARY SYSTEM: EXPERIENCE IN INTRODUCTION AND PROSPECTS

G. M. Pichkhadze , E. M. Satbayeva , L. V. Kisar

Russian Medicine ›› 2012, Vol. 18 ›› Issue (2) : 7 -10.

PDF
Russian Medicine ›› 2012, Vol. 18 ›› Issue (2) : 7 -10. DOI: 10.17816/rmj37959
Articles
research-article

THE FORMULARY SYSTEM: EXPERIENCE IN INTRODUCTION AND PROSPECTS

Author information +
History +
PDF

Abstract

It is known that there are problems in the drug provision (DP) system virtually in all countries irrespective of the level of economic development. Because of money stringency, many countries reduce expenses on DP despite more and more increasing healthcare needs. So the problems, associated with the limited access of the population to qualitative medicaments and their rational use, have not lost their urgency. In this connection, the formulary system in the health care facilities of the Republic of Kazakhstan was studied by analyzing its legislative enactments regulating DP and by interviewing the staff of these facilities (a questionnaire method). The study has demonstrated that in Kazakhstan the formulary system needs to be improved; difficulties preserve in the creation and practical use of a drug form in health care facilities.

Keywords

formulary system / formulary list / drug provision / medicaments / drug procurement

Cite this article

Download citation ▾
G. M. Pichkhadze, E. M. Satbayeva, L. V. Kisar. THE FORMULARY SYSTEM: EXPERIENCE IN INTRODUCTION AND PROSPECTS. Russian Medicine, 2012, 18(2): 7-10 DOI:10.17816/rmj37959

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Бейсенбаева А. А., Гуляев А. Е., Ермекбаева Б. А., Нургожин Т. С. Методические рекомендации по организации внедрения Республиканской (национальной) формулярной системы Министерства здравоохранения Республики Казахстан. — Астана, 2006. — С. 5—6.

[2]

Белоусов Ю. Б., Виноградов В. А. // Фарматека. — 2005. — № 6. — С. 11—15.

[3]

Гуляев А. Е. // Вестн. фармации. — 2009. — № 319. — С. 3—4.

[4]

Из отчета «Подведение итогов по определению победителей среди фармацевтических компаний по закупу лекарственных средств и изделий медицинского назначения на 2011 год единым дистрибьютором ТОО "СК-Фармация"». — 2010. — С. 5—6.

[5]

Политика в области информации о лекарственных средствах в странах Центральной и Восточной Европы и в Новых Независимых Государствах. Отчет о рабочем совещании ВОЗ. — Хилле-ред; Дания, 1996. — С. 1—12.

[6]

WHO medicines strategy 2004—2007. Countries at the core — WH0/EDM/2004.2. C. 1—10.

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF

130

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/